Sun Pharma

• Established in 1983
• Most valuable Pharma company in India
• Reported Turnover growth and profit growth of 10 times in last 10 years.
• Acquisition was the main ingredient of growth : Acquired 16 companies in last 20 years.
• Recent Acquisitions :  TARO (Israel) in 2010, DUSA (US) in 2012, URL Pharma (US) in 2013, Ranbaxy (India) in April 2014.
• Zero debt and Rs.7500 Cr in cash balance gives further scope for acquisition.
• Derives 23% revenue in Indian branded generic market and 60% from US.
• 25 manufacturing facilities in 4 countries.